Article Information
History
- May 10, 2022.
Copyright
The copyright holder for this preprint is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Hajrah Khawaja1,
- Rebecca Briggs1,
- Cheryl Latimer1,
- Md A.M.B. Rassel1,
- Daryl Griffin1,
- Lyndsey Hanson2,
- Alberto Bardelli3,4,
- Frederica Di Nicolantonio3,4,
- Simon McDade1,
- Christopher J. Scott1,
- Shauna Lambe1,
- Manisha Maurya5,
- Andreas Lindner6,
- Jochen H.M. Prehn6,
- Jose Sousa1,7,
- Chris Winnington1,
- Melissa J. LaBonte1,
- Sarah Ross2 and
- Sandra Van Schaeybroeck1,*
- 1Drug Resistance Group, Patrick G. Johnston Centre for Cancer Research, School of Medicine, Dentistry and Biomedical Science, Queen’s University Belfast, 97 Lisburn Road, Belfast, BT9 7AE, United Kingdom
- 2AstraZeneca, Cambridge, CB2 0RE, United Kingdom
- 3Department of Oncology, University of Torino, Candiolo (TO) 10060, Italy
- 4Candiolo Cancer Institute, FPO-IRCCS, Candiolo (TO) 10060, Italy
- 5Precision Medicine Centre of Excellence, Health Sciences Building, Queen’s University Belfast, 97 Lisburn Road, Belfast, BT9 7AE, United Kingdom
- 6Centre of Systems Medicine; Royal College of Surgeons in Ireland University of Medicine and Health Sciences, 123□St. Stephen’s Green, Dublin 2, Ireland
- 7Personal Health Data Science Group, Sano. Centre for Computational Personalised Medicine, Krakow, Poland
- ↵*To whom correspondence should be addressed, at the Patrick G. Johnston Centre for Cancer Research, Queen’s University Belfast, 97 Lisburn Road, Belfast BT9 7AE, Northern Ireland. Tel: 44-2890-972954. Fax: 44-2890-972776. Email: s.vanschaeybroeck{at}qub.ac.uk